BeiGene | Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms

⟵ Back to Search Results

Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms

Beigene Study ID

BGB-A317-207

ClinicalTrials.gov ID

NCT03493451

EudraCT Number

2017-003700-44

China Drug Trials ID

CTR20171387

Sex: All

Age: 18 Years / N/A

Study Protocol Statistical Analysis Plan

Sex: All

Age: 18 Years / N/A

Study Protocol Statistical Analysis Plan